Long-term Prognosis of Left Ventricular Lead by Park, Seung-Jung et al.
© 2010 The Korean Academy of Medical Sciences.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) 
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
pISSN 1011-8934
eISSN 1598-6357
Long-term Prognosis of Left Ventricular Lead 
Transvenous left ventricular (LV) lead implantation is on the increase due to cardiac 
resynchronization therapy (CRT). However, there has been paucity of data on the prognosis 
of LV lead. Consecutive 32 patients with LV lead for CRT (n=22) or pacemaker (n=10) were 
subjected. Serial changes in pacing threshold and impedance along with lead-related 
complications were evaluated. Over 2 yr follow-up, there was no significant change in 
relative threshold voltage to the initial value (100%, 110%, 89.6%, and 79.6% at baseline, 1, 
6, and 24 months respectively, P=0.62) as well as lead impedance (816±272, 650±178, 
647±191, and 590±185 ohm at baseline, 1, 6, and 24 months respectively, P=0.80). The 
threshold change was not affected by lead position, lead polarity, and indication of lead 
implantation. The cumulative rates of lead revision were 6.3% (n=2) and 9.4% (n=3) in 6 
month and 2 yr follow-up, respectively. One case of phrenic nerve capture at left lateral 
decubitus position was detected 1 month after the implantation. However, there were no 
serious complications over 2 yr period. In conclusion, transvenous LV lead implantation 
showed favorable long-term prognosis. Pacing parameters remained stable without 
significant changes over 2 yr follow-up.  
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INTRODUCTION
Transvenous left ventricular (LV) lead implantations have oc-
casionally been used when permanent cardiac pacing is need-
ed for those whom endocardial right ventricular (RV) pacing is 
contraindicated by the presence of a tricuspid valve (TV) pros-
thesis (1, 2). Cardiac resynchronization therapy (CRT) has been 
demonstrated to be beneficial for selected patients with advanc-
 
ed heart failure through several randomized trials. Thereafter, 
number of implantation cases has been increased worldwide 
(3-5). Therefore, information on the efficacy and safety of LV 
leads is becoming much more necessary than ever. There has 
been paucity of data, however, on the prognosis of transvenous 
LV leads after their implantation (6). The aim of this study was 
to evaluate the long-term performance of LV leads implanted 
into cardiac veins and their related complications. 
MATERIALS AND METHODS
Patient population
From November 1996 to December 2008, consecutive 32 patients 
(M:F=14:19, 59.4±12.3 yr) who underwent transvenous LV lead 
implantation at Seoul National University Hospital and Asan 
Medical Center, were enrolled. All the patients underwent the 
procedure either for CRT (n=22) as an adjunctive therapy of se-
vere LV dysfunction (New York Heart Association functional class 
III or IV heart failure despite optimal medical treatment), or for 
permanent pacemaker (PM, n=10) due to complete atrioven-
tricular block (CAVB) or sinus node dysfunction. The study was 
approved by the hospital ethics committee (IRB No. H-1003-
054-313).
LV lead and implantation procedure 
Leads utilized in our study were Attain Unipolar OTW leads 
(model 4193, St. Paul, MN, USA), Attain Bipolar OTW leads 
(model 4194, Medtronic), Attain 2187 leads (Medtronic), and 
QuickSite leads (model 1506T, St. Jude Medical, Sylmar, CA, 
USA). 
  All implantation procedures were done in cardiac electro-
physiology laboratory under conscious sedation with local an-
esthesia. Axillary or subclavian vein was punctured for the trans-
venous deployment of a specialized lead delivery system into 
the cardiac veins. To facilitate the LV lead insertion into the tar-
get sites, cardiac venograms in multiple fluoroscopic projections 
were acquired.  If the pacing threshold in a coronary vein was 
considered too high (>5 V at 0.4 ms), deployment into another 
branch was tried. When the values of LV pacing threshold, R-
wave sensing, and lead impedance were acceptable, the lead 
was connected to a pulse generator. 
   Park S-J, et al.  •  Long-term Prognosis of Left Ventricular Lead 
http://jkms.org   1463 DOI: 10.3346/jkms.2010.25.10.1462
Clinical follow-up
To assess the LV leads performance, serial changes in pacing 
threshold and impedance were analyzed at the time of implan-
tation, 1, 6, 12, and 24 months after the index procedure. Thresh-
old test was performed at 0.4 ms pulse width, and relative thresh-
old voltages to the initial value (%) were obtained at each follow-
up time point. 
Statistical analysis
Continuous variables were presented as mean±standard devia-
tion and were compared using non-parametric Mann-Whitney 
test. The results for categorical variables were described as per-
centages, and the Fisher’s exact test was used to compare them 
when appropriate. Differences in pacing parameters at each 
follow-up period were tested by analysis of variance (ANOVA) 
and followed by a Scheffe’s post-hoc test. All statistical analyses 
were performed using SPSS software, version 17 (SPSS Inc., 
Chicago, IL, USA), and P values of <0.05 were considered statis-
tically significant.
 
RESULTS
Baseline clinical and LV lead characteristics
Baseline clinical characteristics of the patients who underwent 
transvenous LV lead implantation (n=32) are summarized in 
Table 1. Patients with ischemic cardiomyopathy accounted for 
about 16% of total population whereas non-ischemic cardiomy-
opathy did 84%. The LV ejection fraction (EF) of CRT group and 
PM group were 23±8% and 55±8%, respectively. All patients in 
the PM group (n=10) had TV prosthesis, which composed of 4 
cases of mechanical valves and 6 cases of tissue valves (Fig. 1). 
They had already experienced multiple open heart surgery (OHS) 
prior to PM insertion with mean number of OHS and of replaced 
valve were 2.4±0.8 and 2.5±0.5 respectively.  
  Table 2 shows baseline LV lead characteristics. Seven unipo-
lar (22%) and 25 bipolar leads (78%) were used for the patients 
enrolled in the present study. Final deployment sites were as 
follows; 11 in the lateral, 6 in posterolateral, 5 in anterolateral, 2  Table 1. Baseline clinical characteristics 
Number of Patients  32
Age 59.4±12.3 yr
Male/Female (%) 13 (40.6%)/19 (59.4%)
Ischemic/Non-ischemic CMP (%)  5 (15.6%)/27 (84.4%)
Indication (%)
   CRT
   Pacemaking due to SND
   Pacemaking due to CABV
22 (68.8%)
  8 (25.0%)
2 (6.2%)
Echo parameters
   LV ejection fraction
   LV EDD
   LV ESD
34.1±17.4%
    62.2±13.3 mm
    50.6±14.0 mm
Data are number (%) or mean±standard deviation. 
CAVB, complete atrioventricular block; CMP, cardiomyopathy; CRT, cardiac resynchroni-
zation therapy; EDD, end diastolic dimension; ESD, end systolic dimension; LV, left 
ventricular; SND, sinus node dysfunction. 
A B C
Fig. 1. Long-term stability of a left ventricular lead implanted in lateral cardiac veins. LV lead implantation was performed due to both complete atrioventricular block and 
mechanical tricuspid valve (A, B). The lead remained stable without dislodgement for 42 months (C).
mAV, mechanical aortic valve; mMV, mechanical mitral valve; mTV, mechanical tricuspid valve.
mAV
mAV
mAV
mMV
mMV
mMV
mTV
mTV
mTV
LV lead  
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Table 2. Baseline lead characteristics 
Lead location (%)
   Lateral cardiac vein
   Posterolateral cardiac vein
   Anterolateral cardiac vein
   Posterior cardiac vein
   Anterior cardiac veinw
   Middle cardiac vein
11 (34.4%)
  6 (18.8%)
  5 (15.6%)
2 (6.2%)
  5 (15.6%)
3 (9.4%)
Lead polarity (%)
   Unipolar
   Bipolar lead 
  7 (21.9%)
25 (78.1%)
Manufacturer (%)
   Medtronic 
   St. Jude Medical 
28 (87.5%)
  4 (12.5%) 
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in posterior, 5 in anterior, and 3 in middle cardiac vein respec-
tively. 
Serial changes in pacing parameters of transvenous LV lead
Follow-up period was 30.4±26.4 months (1-107 months). As 
shown in Fig. 2, the serial values of pacing parameters of LV 
leads remained stable without significant changes during the 
follow-up period. Relative threshold voltage to the baseline val-
ue (%) at each follow-up point were 110%, 89.6%, and 79.6% at 
1, 6, and 24 months respectively (P=0.62 by ANOVA). The chang-
ing pattern of impedance showed stepwise decreasing trend 
from the initial value of 816±272 ohm to 590±185 ohm during 
the follow-up period (P=0.80 by ANOVA). 
  In addition, there were no significant changes in the thresh-
old voltage over time within several subgroups divided by some 
variables such as LV lead location, procedure indication, or lead 
polarity (Table 3, Fig. 3). For example, in the lateral location group 
(lateral, posterolateral, or anterolateral cardiac vein) LV pacing 
thresholds were 2.0±1.2 V, 2.2±1.2 V, and 2.1±1.2 V at index pro-
cedure, 6 months, and 1 yr, respectively (P=0.63). Similarly, 
change in pacing threshold was not great in the other subgroups 
as well during the follow-up. On the other hand, its values be-
tween the subgroups at the specific follow-up points did not 
show significant differences; lateral versus non-lateral location 
group, CRT versus PM group, and unipolar versus bipolar group 
at baseline, 6 month, and 1 yr respectively (Table 3). 
LV lead-related complications 
The cumulative rates of lead revision due to capture failure were 
3.1% (n=1), 6.3% (n=2), and 9.4% (n=3) in 1 month, 6 month, 
and 2 yr follow-up. At 1 week after the implantation, capture 
failure was developed in the 56 yr-old female patient who had a 
unipolar lead in the lateral cardiac vein for CRT. The other cases 
occurred at 6 week and 19 months after the procedure; 73 yr-old 
male with a unipolar lead in the anterolateral cardiac vein for 
CRT and 39 yr-old female with a unipolar lead in the lateral car-
diac vein for PM. However, any other serious complications such 
as intractable diaphragmatic pacing, coronary sinus perforation, 
or LV lead-related infections requiring lead revision were not 
observed over the two-year follow-up period. Only one case of 
phrenic nerve capture at left lateral decubitus position (50 yr-
old female with a lead in the lateral cardiac vein) was detected  
4 weeks after the implantation. She was educated to avoid lying 
on the left side. Then she has been well managed till now (up to 
30 months) with the pacing parameters remained within stable 
range (threshold of 1.25 V and impedance of 569 ohm).
 
DISCUSSION
According to the recent study that enrolled 136 consecutive pa-
tients who underwent TV replacement surgery, need for per-
manent pacemaker was as high as 21% after the operation (7). 
Moreover, multivalve procedure, especially when including TV 
operation, was one of the strongest independent predictors for 
the need of a pacemaker (8-10). Transvenous RV pacing is, how-
ever, generally contraindicated when the TV prosthesis (espe-
cially mechanical valve) is present, out of concern that the me-
chanical valve and pacemaker lead system might damage each 
other. Epicardial LV pacing through a thoracotomy or sternoto-
my could be a possible alternative in this situation. However, 
these invasive approaches may be too risky (11) and infeasible, 
especially when the patients have already undergone multiple 
open heart surgery. In our study population, mean number of 
operations and replaced valves were 2.4±0.8 and 2.5±0.5 respec-
tively in PM group. Therefore, implantations of cardiac pacing 
Fig. 2. Pacing parameters remain stable without significant changes over 2 yr follow-
up. There was no significant change in relative threshold voltage to the initial value as 
well as lead impedance over 2 yr follow-up. 
*Relative threshold (%)=follow-up voltage/initial voltage×100. 
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Table 3. Serial changes in LV lead threshold* in various subgroups
Lead Position  Lateral vein (n=22)
† Non-lateral vein (n=10)
† P value
‡
Initial  2.0±1.2 V 2.1±1.6 V 0.95
6 months 2.2±1.2 V 1.7±0.8 V 0.28
1 yr 2.1±1.3 V 1.7±0.9 V 0.75
P value over time 0.63 0.73
Indication  CRT (n=22) PM (n=10)
Initial  1.8±1.2 V 2.6±1.3 V  0.08
6 months 2.1±0.8 V 2.2±1.2 V 0.82
1 yr 1.8±1.0 V 2.1±1.4 V 0.68
P value over time 0.68 0.64
 Lead Polarity Unipolar (n=25) Bipolar (n=7)
Initial  1.9±1.3 V 2.4±1.4 V 0.36
6 months 1.9±0.8 V 2.3±0.9 V 0.41
1 yr 1.8±1.0 V   2.5±1.7 V 0.23
P value over time 0.85 0.95
Data are number (%) or mean±standard deviation. 
*Threshold tests were done at 0.4 ms pulse width; 
†Lateral position indicates the cases 
in which the pacing leads were implanted into lateral, posterolateral, or anterolateral 
cardiac vein whereas non-lateral position posterior, anterior, or middle cardiac vein; 
‡P value between subgroups at each time point.
CRT, cardiac resynchronization therapy; LV, left ventricular; PM, permanent pacemaker. Park S-J, et al.  •  Long-term Prognosis of Left Ventricular Lead 
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leads into the coronary sinus would be the best option for these 
specific situations. However, there have been only a few case 
reports about the LV leads implanted in the presence of TV pros-
thesis and their long-term performance (1, 2). 
  Aside from the cases with mechanical TV prosthesis, trans-
venous LV lead implantation rate is continuously increasing as 
CRT has been known to improve survival and quality of life in 
patients with advanced heart failure and dyssynchrony (3, 4). 
This increasing enthusiasm for CRT makes data on the long-
term performance and safety of transvenous LV lead implanta-
tion more important. Of course, epicardial LV lead placement 
through surgical approach is also possible alternative for CRT. 
However, open chest surgery must be a great burden on the pa-
tients with advanced symptomatic heart failure. Despite these 
situations, little is still known on the stability of leads deployed 
into the cardiac veins for CRT as is for PM after TV replacement 
surgery. Although a multicenter study over 2,000 patients on 
this subject was carried out, its result was in part limited by short 
follow-up duration of 6 months (6).  
  In this study, long-term performance of LV lead was stable 
and favorable with no significant changes in its position (Fig. 1C) 
and in pacing parameters over the 2 yr (Fig. 2). The LV lead revi-
sion rate due to capture failure were 6.3% (n=2) and 9.4% (n=3) 
in 6 month and 2 yr follow-up respectively, which are very simi-
lar to the outcomes of previous reports (6, 12, 13). Although lim-
ited by small sample size, lead revision rate of PM group (1 out 
of 10) did not seem to be significantly different from that of CRT 
group (2 out of 22). This revision rate might be thought some-
Lead threshold Lead impedance 
Fig. 3. Serial changes in LV pacing threshold and impedance in various subgroups. Long-term stabilities in threshold voltage and lead impedance are still maintained in various 
subgroups divided depending on lead position, lead polarity, and indication of lead implantation.
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what high compared to that of RV pacing lead, which was recent-
ly reported to be 1.5% to 3.3% (14, 15). However, LV lead revision 
rate is sure to decrease to a lower level in the near future through 
rapid advancement in lead design and technology as was true 
with RV lead; dislodgement rate of first generation RV lead once 
reached 18% (16). In terms of the other complication, we detect-
ed one case of phrenic nerve capture (3.1%) over 2 yr observa-
tion, which is also comparable to the previous reports (1% to 3%) 
(6, 12). Any other serious problems such as cardiac vein perfo-
ration or infection were not found in this study. 
  As already mentioned, LV lead pacing threshold remained 
stable over 2 yr without significant changes. This stability was 
still maintained in various subgroups divided according to some 
variables including lead deployment position, indication of im-
plantation, or lead polarity (Table 3). 
  Although present study is a retrospective analysis of small 
sized cohort, this was the first report on the long-term progno-
sis of LV lead in Korea and our data represent an addition to a 
very limited number of published reports on this subject. In ad-
dition, to the best of our knowledge, this is the largest case series 
study worldwide on the performance of transvenous LV lead in 
the presence of TV prosthesis. 
  Taken all together, transvenous LV lead implantation seems 
safe and feasible procedure with favorable stability for CRT or 
PM in the presence of TV prosthesis. Systematic, larger-scale 
studies are needed for the future considering the steep increase 
in the rate of LV lead procedure.
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